{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:02:03Z","timestamp":1788912123002,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00576","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T16:53:46Z","timestamp":1588265626000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Apolipoprotein A-I Mimetic Peptide L-4F Suppresses Granulocytic-Myeloid-Derived Suppressor Cells in Mouse Pancreatic Cancer"],"prefix":"10.3389","volume":"11","author":[{"given":"Meiyu","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyu","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongzhen","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"678","DOI":"10.4049\/jimmunol.166.1.678","article-title":"Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer","volume":"166","author":"Almand","year":"2001","journal-title":"J. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","article-title":"Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function","volume":"32","author":"Condamine","year":"2011","journal-title":"Trends Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells","volume":"182","author":"Corzo","year":"2009","journal-title":"J. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00262-008-0523-4","article-title":"Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy","volume":"58","author":"Diaz-Montero","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1053\/j.seminoncol.2014.02.003","article-title":"Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications","volume":"41","author":"Diaz-Montero","year":"2014","journal-title":"Semin. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/eji.201545493","article-title":"Versatile myeloid cell subsets contribute to tuberculosis-associated inflammation","volume":"45","author":"Dorhoi","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/ijc.26123","article-title":"Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer","volume":"130","author":"Eruslanov","year":"2012","journal-title":"Int. J. Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.intimp.2011.01.030","article-title":"MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy","volume":"11","author":"Finke","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00262-011-1028-0","article-title":"Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13","volume":"60","author":"Gabitass","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1161\/01.RES.0000176530.66400.48","article-title":"Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide","volume":"97","author":"Gupta","year":"2005","journal-title":"Circ. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jim.2012.04.004","article-title":"Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples","volume":"381","author":"Kotsakis","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1172\/JCI35213","article-title":"Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice","volume":"118","author":"Kujawski","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","article-title":"Tumor-induced tolerance and immune suppression depend on the C\/EBPbeta transcription factor","volume":"32","author":"Marigo","year":"2010","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/CJI.0b013e318242169f","article-title":"Myeloid-derived suppressor cells in cancer patients: a clinical perspective","volume":"35","author":"Montero","year":"2012","journal-title":"J. Immunother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s00262-011-1029-z","article-title":"Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4(+) T cells from patients with GI malignancy","volume":"60","author":"Mundy-Bosse","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/bcr3473","article-title":"A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model","volume":"15","author":"Oh","year":"2013","journal-title":"Breast Cancer Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00262-010-0855-8","article-title":"Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity","volume":"59","author":"Ostrand-Rosenberg","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/bs.acr.2015.04.002","article-title":"Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment","volume":"128","author":"Parker","year":"2015","journal-title":"Adv. Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.canlet.2014.08.011","article-title":"Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune suppressive cells","volume":"354","author":"Peng","year":"2014","journal-title":"Cancer Lett."},{"key":"B22","doi-asserted-by":"publisher","first-page":"99693","DOI":"10.18632\/oncotarget.21157","article-title":"Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1194\/jlr.M800046-JLR200","article-title":"L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice","volume":"49","author":"Peterson","year":"2008","journal-title":"J. Lipid Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00262-011-1178-0","article-title":"Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth","volume":"61","author":"Porembka","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates T-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s10753-014-9864-7","article-title":"L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils","volume":"37","author":"Sharifov","year":"2014","journal-title":"Inflammation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1182\/blood-2010-12-325753","article-title":"A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells","volume":"118","author":"Solito","year":"2011","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ki.2009.177","article-title":"In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide","volume":"76","author":"Vaziri","year":"2009","journal-title":"Kidney Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1385\/IJGC:29:1:37","article-title":"Clinically Relevant Animal Model of Metastatic Pancreatic Adenocarcinoma Biology and Therapy","volume":"29","author":"Wang","year":"2001","journal-title":"Int. J. Gastrointest. Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.semarthrit.2015.07.003","article-title":"The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis","volume":"45","author":"Wang","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.4049\/jimmunol.1200068","article-title":"Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway","volume":"189","author":"Wu","year":"2012","journal-title":"J. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.4103\/0366-6999.180519","article-title":"L-4F Inhibits Oxidized Low-density Lipoprotein-induced Inflammatory Adipokine Secretion via Cyclic AMP\/Protein Kinase A-CCAAT\/Enhancer Binding Protein beta Signaling Pathway in 3T3-L1 Adipocytes","volume":"129","author":"Xie","year":"2016","journal-title":"Chin Med. J. (Engl)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1158\/0008-5472.CAN-08-4323","article-title":"Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells","volume":"69","author":"Xin","year":"2009","journal-title":"Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J. Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00576\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T16:53:47Z","timestamp":1588265627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00576\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":34,"alternative-id":["10.3389\/fphar.2020.00576"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00576","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"article-number":"576"}}